Related Experiment Video
Updated: May 19, 2026

Dextran Labeling and Uptake in Live and Functional Murine Cochlear Hair Cells
Published on: February 8, 2020
A Newly Identified Role of the Tectorial Membrane in Aminoglycoside Ototoxicity
George W S Burwood1, Pierre Hakizimana2, Teresa Wilson1
1Oregon Hearing Research Center, Department of Otolaryngology - Head & Neck Surgery, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR, 97239, USA.
Abstract:
Aminoglycoside (AG) antibiotic safety is limited by ototoxicity, the mitigation of which is vital considering bacterial resistance mediated erosion of our antibiotic arsenal. Previously, we observed tectorial membrane (TM) sequestration of Ca2+. We hypothesized that the TM sequesters other cations, including the AG gentamicin. We proposed to test the effect of TM genetic ablation on ototoxicity and TM-AG sequestration. After intraperitoneal AG-furosemide, TM-lacking Tecta ΔENT/ΔENT mice showed limited outer hair cell loss, unlike wildtype littermates. Spectroscopy measurements of gentamicin-Texas red (GTTR) were made in isolated wildtype and Tecta Y1870C TMs and guinea pig cochleae following direct or intraperitoneal GTTR administration. TM-GTTR sequestration was observed in all cases, while negatively correlated with Tecta Y1870C zygosity. In summary, we discovered a novel TM component in the AG ototoxicity pathway. Intact TM structure is necessary for sequestration, and the TM modulates AG ototoxicity. TM-GTTR sequestration following systemic injection indicates that this phenomenon occurs during AG therapy.
Insights
Aminoglycoside antibiotics can cause hearing loss. Our study reveals the inner ear's tectorial membrane sequesters these drugs, suggesting a new target to prevent ototoxicity.
Area of Science:
- Inner ear biology
- Ototoxicity mechanisms
- Drug safety
Background:
- Aminoglycoside (AG) antibiotics are crucial but limited by ototoxicity.
- The tectorial membrane (TM) in the inner ear sequesters calcium ions.
- AG ototoxicity is a significant clinical concern due to rising antibiotic resistance.
Purpose of the Study:
- To investigate the tectorial membrane's role in aminoglycoside ototoxicity.
- To determine if the TM sequesters aminoglycosides.
- To assess the impact of TM genetic ablation on AG-induced ototoxicity.
Main Methods:
- Genetic ablation of the tectorial membrane in TectaΔENT/ΔENT mice.
- Administration of AG-furosemide and observation of outer hair cell loss.
- Spectroscopy measurements of gentamicin-Texas Red (GTTR) in isolated TMs and cochleae.
Main Results:
- TM-lacking mice showed significantly reduced outer hair cell loss after AG administration.
- Tectorial membranes were found to sequester gentamicin.
- Gentamicin sequestration in the TM was negatively correlated with TectaY1870C zygosity.
Conclusions:
- The tectorial membrane is a novel component in the aminoglycoside ototoxicity pathway.
- Intact TM structure is necessary for AG sequestration and modulation of ototoxicity.
- TM sequestration of AGs occurs during systemic therapy, indicating a potential therapeutic target.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
The Cochlea
Anatomy of the Ear
Hair Cells
Ligand-Gated Ion Channel Receptor: Gating Mechanism

